Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease
McCarty MF, OKeefe JH, DiNicolantonio JJ
Our platform enables high-sensitivity detection of short-, medium-, and long-chain acylcarnitines (C0C18) and free L-carnitine from plasma, serum, tissue, and cell samples
The functionality of GLP-1R/CRE Luciferase Reporter HEK293 Cell Line was validated in dose-response assays using the peptide agonists Glucagon-like peptide 1 (7-37), Exendin-4, Lixisenatide, GLP-1 moiety from dulaglutide, Semaglutide, Tirzepatide and Retatrutide
Participants were drawn from the companys proprietary Shopper Community of more than 40,000 demographically diverse consumers nationwide.